Effect evaluation of levofloxacin combined wtih Jingangteng particle in the treatment of chronic pelvic inflam-matory disease
10.3760/cma.j.issn.1008-6706.2016.01.022
- VernacularTitle:左氧氟沙星联合金刚藤颗粒治疗慢性盆腔炎的疗效评价
- Author:
Yao ZHOU
;
Xiao XU
- Publication Type:Journal Article
- Keywords:
Pelvic disease;
Levofloxacin;
Jingangteng particle
- From:
Chinese Journal of Primary Medicine and Pharmacy
2016;(1):77-80,81
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical effect of levofloxacin combined with Jingangteng particle in the treatment of patients with chronic pelvic inflammatory disease.Methods According to the random number table, sixty -four patients with chronic pelvic inflammatory disease were divided into control group(n =32)which were treated with levofloxacin and treatment group(n =32)which were treated with levofloxacin and Jingangteng particle for three weeks.The clinical effect,symptoms and signs were evaluated and the adverse reactions between the two groups were observed as well as serum C reactive protein(CRP)were measured before and after treatment.Results The score of symptoms and signs of the treatment group were significantly lower than the control group,the difference was statistically significant [(2.61 ±2.09 )points vs.(5.32 ±3.28)points,t =3.941,P =0.000;(1.47 ± 1.02)points vs.(2.56 ±2.04)points,t =2.703,P =0.008].The level of serum CRP of the control group was (5.46 ± 1.93)mg/L,which was statistically higher than (3.76 ±1.06)mg/L of the treatment group after treatment,the differ-ence was statistically significant (t =4.367,P =0.000).The total effective rate of the treatment group was 96.9%, which of the control group was 78.1%,the difference between the two groups were statistically significant(χ2 =5.142,P =0.023).There was no significant adverse reactions during the treatment.Conclusion Levofloxacin com-bined with Jingangteng particle can obviously improve the symptoms and signs of chronic pelvic inflammatory disease, they have good safety and are worthy of clinical popularization and application.
